bcr_patient_barcode	type	age_at_initial_pathologic_diagnosis	gender	race	clinical_stage	histological_type	histological_grade	menopause_status	tumor_status	new_tumor_event_type	treatment_outcome_first_course	OS	OS.time	DSS	DSS.time	DFI	DFI.time	PFI	PFI.time	smoking
TCGA-2W-A8YY	CESC	51	FEMALE	WHITE	Stage_IB2	Adenosquamous	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	533	0	533	0	533	0	533	4
TCGA-4J-AA1J	CESC	31	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	542	0	542	0	542	0	542	1
TCGA-BI-A0VR	CESC	53	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	1505	0	1505	NA	NA	0	1505	4
TCGA-BI-A0VS	CESC	48	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1735	0	1735	0	1735	0	1735	2
TCGA-BI-A20A	CESC	49	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	720	0	720	0	720	0	720	NA
TCGA-C5-A0TN	CESC	21	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	348	1	348	NA	NA	1	62	1
TCGA-C5-A1BE	CESC	64	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Complete_Remission/Response	1	2094	1	2094	1	1674	1	1674	3
TCGA-C5-A1BF	CESC	46	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G1	NA	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	570	1	570	1	93	1	93	2
TCGA-C5-A1BI	CESC	31	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1112	0	1112	0	1112	0	1112	2
TCGA-C5-A1BJ	CESC	34	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	4385	0	4385	0	4385	0	4385	4
TCGA-C5-A1BK	CESC	36	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	5385	0	5385	0	5385	0	5385	1
TCGA-C5-A1BL	CESC	32	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	5271	0	5271	0	5271	0	5271	4
TCGA-C5-A1BM	CESC	78	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	2520	0	2520	0	2520	0	2520	4
TCGA-C5-A1BN	CESC	26	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	1	166	1	166	NA	NA	1	166	2
TCGA-C5-A1BQ	CESC	65	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Partial_Remission/Response	1	604	1	604	NA	NA	0	604	4
TCGA-C5-A1M5	CESC	53	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Indeterminate_(neither_Pre_or_Postmenopausal)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	2052	1	2052	1	693	1	693	1
TCGA-C5-A1M6	CESC	55	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	955	1	955	1	316	1	316	1
TCGA-C5-A1M7	CESC	37	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1409	0	1409	0	1409	0	1409	2
TCGA-C5-A1M8	CESC	43	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Indeterminate_(neither_Pre_or_Postmenopausal)	TUMOR_FREE	NA	Complete_Remission/Response	0	919	0	919	0	919	0	919	1
TCGA-C5-A1M9	CESC	46	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	1065	1	1065	1	555	1	555	1
TCGA-C5-A1ME	CESC	40	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1756	0	1756	0	1756	0	1756	4
TCGA-C5-A1MF	CESC	49	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1617	0	1617	0	1617	0	1617	4
TCGA-C5-A1MH	CESC	71	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	1186	1	1186	1	178	1	178	3
TCGA-C5-A1MI	CESC	50	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	1083	1	1083	1	805	1	805	2
TCGA-C5-A1MJ	CESC	61	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	1	14	0	14	NA	NA	0	14	1
TCGA-C5-A1MK	CESC	79	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	74	1	74	NA	NA	1	74	1
TCGA-C5-A1ML	CESC	49	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	636	1	636	NA	NA	1	636	2
TCGA-C5-A1MN	CESC	42	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	1	1245	0	1245	0	1245	0	1245	2
TCGA-C5-A1MP	CESC	34	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	109	0	109	0	109	0	109	1
TCGA-C5-A1MQ	CESC	35	FEMALE	WHITE	Stage_IIA	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	1031	0	1031	0	1031	0	1031	1
TCGA-C5-A2LS	CESC	37	FEMALE	WHITE	Stage_IB2	Endocervical_Adenocarcinoma_of_the_Usual_Type	G1	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	1345	0	1345	0	1345	0	1345	2
TCGA-C5-A2LT	CESC	38	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	2226	0	2226	0	2226	0	2226	2
TCGA-C5-A2LV	CESC	36	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	2234	0	2234	0	2234	0	2234	2
TCGA-C5-A2LX	CESC	54	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2526	0	2526	0	2526	0	2526	2
TCGA-C5-A2LY	CESC	30	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	2383	0	2383	0	2383	0	2383	1
TCGA-C5-A2LZ	CESC	65	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	3046	1	3046	1	2893	1	2893	2
TCGA-C5-A2M1	CESC	37	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1169	0	1169	0	1169	0	1169	1
TCGA-C5-A2M2	CESC	56	FEMALE	WHITE	Stage_IB2	Endocervical_Type_of_Adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	1	1011	NA	1011	NA	NA	0	1011	4
TCGA-C5-A3HD	CESC	51	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	1582	0	1582	0	1582	0	1582	4
TCGA-C5-A3HE	CESC	44	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	NA	NA	Locoregional_Recurrence	NA	0	548	0	548	NA	NA	1	252	1
TCGA-C5-A3HF	CESC	24	FEMALE	WHITE	Stage_IB2	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	NA	1	543	1	543	NA	NA	1	450	2
TCGA-C5-A3HL	CESC	76	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	621	0	621	0	621	0	621	1
TCGA-C5-A7CG	CESC	55	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	0	6408	0	6408	NA	NA	0	6408	1
TCGA-C5-A7CH	CESC	43	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	0	4694	0	4694	NA	NA	0	4694	1
TCGA-C5-A7CJ	CESC	42	FEMALE	WHITE	Stage_IIA	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	1	3097	0	3097	NA	NA	0	3097	2
TCGA-C5-A7CK	CESC	58	FEMALE	WHITE	Stage_IVA	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	1	4086	0	4086	NA	NA	0	4086	5
TCGA-C5-A7CL	CESC	48	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	WITH_TUMOR	NA	NA	1	471	1	471	NA	NA	1	471	2
TCGA-C5-A7CM	CESC	35	FEMALE	WHITE	Stage_IB2	Endocervical_Adenocarcinoma_of_the_Usual_Type	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	619	0	619	0	619	0	619	4
TCGA-C5-A7CO	CESC	68	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	4482	0	4482	0	4482	0	4482	3
TCGA-C5-A7UC	CESC	48	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	1	523	0	523	NA	NA	0	523	NA
TCGA-C5-A7UE	CESC	45	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	4738	0	4738	0	4738	0	4738	2
TCGA-C5-A7UH	CESC	55	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	0	3988	0	3988	NA	NA	0	3988	1
TCGA-C5-A7UI	CESC	42	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	1	2888	0	2888	NA	NA	0	2888	2
TCGA-C5-A7X3	CESC	70	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	1	284	0	284	NA	NA	0	284	1
TCGA-C5-A7X5	CESC	72	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	NA	NA	1	414	1	414	NA	NA	1	414	NA
TCGA-C5-A7X8	CESC	35	FEMALE	WHITE	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	NA	TUMOR_FREE	NA	NA	0	83	0	83	NA	NA	0	83	2
TCGA-C5-A7XC	CESC	26	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	0	1551	0	1551	NA	NA	0	1551	2
TCGA-C5-A8XH	CESC	39	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	NA	NA	TUMOR_FREE	NA	NA	1	1394	0	1394	NA	NA	0	1394	4
TCGA-C5-A8XI	CESC	69	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	254	0	254	NA	NA	0	254	2
TCGA-C5-A8XJ	CESC	74	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	NA	NA	TUMOR_FREE	NA	NA	0	4467	0	4467	NA	NA	0	4467	1
TCGA-C5-A8XK	CESC	30	FEMALE	BLACK_OR_AFRICAN_AMERICAN	NA	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	0	3039	0	3039	NA	NA	0	3039	NA
TCGA-C5-A8YQ	CESC	79	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	715	1	715	NA	NA	1	715	2
TCGA-C5-A8YR	CESC	56	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	NA	NA	Locoregional_Recurrence	NA	1	837	NA	837	NA	NA	1	272	1
TCGA-C5-A8YT	CESC	36	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	NA	NA	1	633	1	633	NA	NA	1	633	2
TCGA-C5-A8ZZ	CESC	41	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	0	636	0	636	NA	NA	0	636	2
TCGA-C5-A907	CESC	47	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	0	448	0	448	NA	NA	0	448	4
TCGA-DG-A2KH	CESC	25	FEMALE	NA	Stage_IB1	Adenosquamous	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	NA	NA	NA	0	34	0	34	NA	NA	0	34	4
TCGA-DG-A2KJ	CESC	50	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	2893	0	2893	0	2893	0	2893	NA
TCGA-DG-A2KK	CESC	51	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2496	0	2496	0	2496	0	2496	4
TCGA-DG-A2KL	CESC	53	FEMALE	NA	Stage_IIA	Cervical_Squamous_Cell_Carcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1367	0	1367	0	1367	0	1367	2
TCGA-DG-A2KM	CESC	46	FEMALE	NA	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	1946	0	1946	0	1946	0	1946	1
TCGA-DR-A0ZL	CESC	53	FEMALE	ASIAN	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2669	0	2669	0	2669	0	2669	1
TCGA-DR-A0ZM	CESC	61	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1791	0	1791	0	1791	0	1791	2
TCGA-DS-A0VK	CESC	45	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	1118	1	1118	NA	NA	1	209	4
TCGA-DS-A0VL	CESC	25	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	81	0	81	0	81	0	81	1
TCGA-DS-A0VM	CESC	51	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	Distant_Metastasis	Complete_Remission/Response	0	3589	0	3589	1	868	1	868	1
TCGA-DS-A0VN	CESC	47	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	3609	0	3609	0	3609	0	3609	1
TCGA-DS-A1OA	CESC	77	FEMALE	ASIAN	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Locoregional_Recurrence	NA	1	879	1	879	NA	NA	1	379	1
TCGA-DS-A3LQ	CESC	46	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	699	0	699	0	699	0	699	3
TCGA-DS-A5RQ	CESC	80	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	512	0	512	0	512	0	512	2
TCGA-DS-A7WF	CESC	41	FEMALE	NA	Stage_IB2	Adenosquamous	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Partial_Remission/Response	1	492	1	492	NA	NA	1	321	2
TCGA-DS-A7WH	CESC	34	FEMALE	WHITE	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	533	0	533	0	533	0	533	1
TCGA-DS-A7WI	CESC	43	FEMALE	WHITE	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	252	1	252	1	206	1	206	1
TCGA-EA-A1QS	CESC	46	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1203	0	1203	0	1203	0	1203	1
TCGA-EA-A1QT	CESC	47	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1243	0	1243	0	1243	0	1243	1
TCGA-EA-A3HQ	CESC	60	FEMALE	WHITE	Stage_II	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1136	0	1136	0	1136	0	1136	1
TCGA-EA-A3HR	CESC	57	FEMALE	WHITE	Stage_II	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	940	0	940	0	940	0	940	1
TCGA-EA-A3HS	CESC	35	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	959	0	959	0	959	0	959	1
TCGA-EA-A3HT	CESC	68	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	954	0	954	0	954	0	954	1
TCGA-EA-A3HU	CESC	43	FEMALE	WHITE	Stage_II	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1013	0	1013	0	1013	0	1013	1
TCGA-EA-A3QD	CESC	59	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	397	0	397	0	397	0	397	1
TCGA-EA-A3QE	CESC	45	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	761	0	761	0	761	0	761	1
TCGA-EA-A3Y4	CESC	40	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1122	0	1122	0	1122	0	1122	1
TCGA-EA-A410	CESC	51	FEMALE	WHITE	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	803	0	803	0	803	0	803	1
TCGA-EA-A411	CESC	50	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	747	0	747	0	747	0	747	1
TCGA-EA-A439	CESC	50	FEMALE	ASIAN	Stage_IIA1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	Locoregional_Recurrence	Complete_Remission/Response	0	965	0	965	1	316	1	316	1
TCGA-EA-A43B	CESC	43	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	791	0	791	0	791	0	791	1
TCGA-EA-A44S	CESC	31	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Stable_Disease	0	369	0	369	NA	NA	0	369	1
TCGA-EA-A4BA	CESC	49	FEMALE	WHITE	Stage_IB2	Endocervical_Type_of_Adenocarcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	755	0	755	0	755	0	755	1
TCGA-EA-A50E	CESC	45	FEMALE	ASIAN	Stage_IVA	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	227	1	227	NA	NA	1	208	1
TCGA-EA-A556	CESC	38	FEMALE	WHITE	Stage_IB1	Endometrioid_Adenocarcinoma_of_Endocervix	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	453	0	453	0	453	0	453	2
TCGA-EA-A5FO	CESC	59	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	815	0	815	0	815	0	815	1
TCGA-EA-A5O9	CESC	39	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	788	0	788	0	788	0	788	1
TCGA-EA-A5ZD	CESC	40	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	830	0	830	0	830	0	830	1
TCGA-EA-A5ZE	CESC	54	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	Distant_Metastasis	Complete_Remission/Response	0	829	0	829	1	425	1	425	1
TCGA-EA-A5ZF	CESC	56	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	828	0	828	1	440	1	440	1
TCGA-EA-A6QX	CESC	49	FEMALE	ASIAN	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	730	0	730	0	730	0	730	1
TCGA-EA-A78R	CESC	54	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	410	0	410	0	410	0	410	1
TCGA-EA-A97N	CESC	38	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	11	0	11	0	11	0	11	1
TCGA-EK-A2GZ	CESC	64	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	0	383	0	383	NA	NA	0	383	NA
TCGA-EK-A2H0	CESC	24	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1847	0	1847	0	1847	0	1847	NA
TCGA-EK-A2H1	CESC	20	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	0	799	0	799	NA	NA	0	799	NA
TCGA-EK-A2IP	CESC	28	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	NA	NA	NA	0	202	0	202	NA	NA	0	202	NA
TCGA-EK-A2PG	CESC	88	FEMALE	BLACK_OR_AFRICAN_AMERICAN	NA	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	46	0	46	NA	NA	0	46	NA
TCGA-EK-A2PI	CESC	44	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	WITH_TUMOR	NA	NA	0	586	0	586	NA	NA	0	586	NA
TCGA-EK-A2PK	CESC	43	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Indeterminate_(neither_Pre_or_Postmenopausal)	TUMOR_FREE	NA	NA	0	12	0	12	NA	NA	0	12	NA
TCGA-EK-A2PL	CESC	36	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	NA	NA	WITH_TUMOR	NA	NA	0	13	0	13	NA	NA	0	13	NA
TCGA-EK-A2PM	CESC	81	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	0	18	0	18	NA	NA	0	18	NA
TCGA-EK-A2R7	CESC	45	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	0	27	0	27	NA	NA	0	27	NA
TCGA-EK-A2R8	CESC	48	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	NA	0	44	0	44	NA	NA	0	44	NA
TCGA-EK-A2R9	CESC	58	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	NA	NA	0	4	0	4	NA	NA	0	4	NA
TCGA-EK-A2RA	CESC	74	FEMALE	NA	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	NA	NA	0	1246	0	1246	NA	NA	0	1246	4
TCGA-EK-A2RB	CESC	48	FEMALE	WHITE	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	0	9	0	9	NA	NA	0	9	2
TCGA-EK-A2RC	CESC	33	FEMALE	NA	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	0	129	0	129	NA	NA	0	129	NA
TCGA-EK-A2RE	CESC	26	FEMALE	WHITE	Stage_IIA	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	0	57	0	57	NA	NA	0	57	NA
TCGA-EK-A2RJ	CESC	51	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	NA	0	53	0	53	NA	NA	0	53	NA
TCGA-EK-A2RK	CESC	67	FEMALE	WHITE	Stage_IA2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	13	0	13	NA	NA	0	13	NA
TCGA-EK-A2RL	CESC	32	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB	Endocervical_Type_of_Adenocarcinoma	G2	NA	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	1453	1	1453	NA	NA	1	1143	NA
TCGA-EK-A2RM	CESC	40	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	NA	NA	0	50	0	50	NA	NA	0	50	NA
TCGA-EK-A2RN	CESC	45	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	0	71	0	71	NA	NA	0	71	NA
TCGA-EK-A2RO	CESC	59	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	0	2	0	2	NA	NA	0	2	NA
TCGA-EK-A3GJ	CESC	51	FEMALE	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	NA	NA	NA	0	3	0	3	NA	NA	0	3	NA
TCGA-EK-A3GK	CESC	33	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G3	NA	TUMOR_FREE	NA	NA	0	15	0	15	NA	NA	0	15	NA
TCGA-EK-A3GM	CESC	65	FEMALE	WHITE	Stage_IIA	Endocervical_Type_of_Adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	0	0	0	NA	NA	0	0	1
TCGA-EK-A3GN	CESC	47	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	NA	NA	0	27	0	27	NA	NA	0	27	NA
TCGA-EX-A1H5	CESC	58	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	619	0	619	0	619	0	619	2
TCGA-EX-A1H6	CESC	38	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	241	0	241	0	241	0	241	1
TCGA-EX-A3L1	CESC	32	FEMALE	WHITE	Stage_IIA1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	463	0	463	0	463	0	463	1
TCGA-EX-A69L	CESC	41	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	602	0	602	0	602	0	602	1
TCGA-EX-A69M	CESC	62	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	New_Primary_Tumor	Complete_Remission/Response	1	253	0	253	0	253	1	77	4
TCGA-EX-A8YF	CESC	44	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	0	473	0	473	1	396	1	396	1
TCGA-FU-A23K	CESC	28	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	372	0	372	0	372	0	372	1
TCGA-FU-A23L	CESC	60	FEMALE	WHITE	Stage_IIA1	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	725	0	725	0	725	0	725	1
TCGA-FU-A2QG	CESC	29	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	579	0	579	0	579	0	579	4
TCGA-FU-A3EO	CESC	55	FEMALE	WHITE	Stage_IIB	Endocervical_Type_of_Adenocarcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	490	0	490	0	490	0	490	2
TCGA-FU-A3HY	CESC	47	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	954	0	954	0	954	0	954	2
TCGA-FU-A3HZ	CESC	64	FEMALE	WHITE	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1103	0	1103	0	1103	0	1103	1
TCGA-FU-A3NI	CESC	45	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	1	638	0	638	NA	NA	0	638	2
TCGA-FU-A3TQ	CESC	55	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	795	0	795	0	795	0	795	2
TCGA-FU-A3TX	CESC	78	FEMALE	NA	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	NA	NA	NA	0	45	0	45	NA	NA	0	45	4
TCGA-FU-A3WB	CESC	43	FEMALE	WHITE	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	491	0	491	0	491	0	491	4
TCGA-FU-A3YQ	CESC	35	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	861	0	861	0	861	0	861	2
TCGA-FU-A40J	CESC	38	FEMALE	WHITE	Stage_IIIB	Endocervical_Type_of_Adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	426	0	426	0	426	0	426	1
TCGA-FU-A57G	CESC	49	FEMALE	WHITE	Stage_IB2	Endocervical_Type_of_Adenocarcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1078	0	1078	0	1078	0	1078	1
TCGA-FU-A5XV	CESC	32	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	321	0	321	0	321	0	321	2
TCGA-FU-A770	CESC	33	FEMALE	WHITE	Stage_IIIB	Endocervical_Adenocarcinoma_of_the_Usual_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	0	34	0	34	NA	NA	0	34	2
TCGA-GH-A9DA	CESC	27	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	540	0	540	0	540	0	540	2
TCGA-HG-A2PA	CESC	38	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Complete_Remission/Response	1	773	1	773	NA	NA	1	773	2
TCGA-HM-A3JJ	CESC	40	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	659	1	659	1	385	1	385	NA
TCGA-HM-A3JK	CESC	64	FEMALE	WHITE	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	632	0	632	0	632	0	632	4
TCGA-HM-A4S6	CESC	51	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	454	0	454	0	454	0	454	3
TCGA-HM-A6W2	CESC	34	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IVB	Adenosquamous	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	287	0	287	NA	NA	0	287	2
TCGA-IR-A3L7	CESC	37	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	4483	0	4483	0	4483	0	4483	4
TCGA-IR-A3LA	CESC	60	FEMALE	WHITE	Stage_IB1	Endometrioid_Adenocarcinoma_of_Endocervix	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	4172	0	4172	0	4172	0	4172	1
TCGA-IR-A3LB	CESC	53	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	2032	1	2032	1	317	1	317	3
TCGA-IR-A3LC	CESC	40	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	3935	0	3935	0	3935	0	3935	1
TCGA-IR-A3LF	CESC	64	FEMALE	WHITE	Stage_IB1	Endocervical_Adenocarcinoma_of_the_Usual_Type	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	2949	0	2949	0	2949	0	2949	1
TCGA-IR-A3LH	CESC	49	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIA1	Cervical_Squamous_Cell_Carcinoma	G4	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	2394	0	2394	0	2394	0	2394	4
TCGA-IR-A3LI	CESC	48	FEMALE	WHITE	Stage_IVB	Endocervical_Type_of_Adenocarcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	2493	0	2493	NA	NA	0	2493	1
TCGA-IR-A3LK	CESC	69	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	1	908	1	908	1	574	1	574	1
TCGA-IR-A3LL	CESC	60	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1106	0	1106	0	1106	0	1106	1
TCGA-JW-A5VG	CESC	35	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IIA	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	834	0	834	0	834	0	834	1
TCGA-JW-A5VH	CESC	53	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	100	1	100	NA	NA	1	94	1
TCGA-JW-A5VI	CESC	45	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	747	0	747	1	558	1	558	2
TCGA-JW-A5VJ	CESC	56	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	0	652	0	652	NA	NA	1	267	1
TCGA-JW-A5VK	CESC	43	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	623	0	623	0	623	0	623	3
TCGA-JW-A5VL	CESC	37	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	474	0	474	0	474	0	474	1
TCGA-JW-A69B	CESC	44	FEMALE	WHITE	Stage_IB2	Endocervical_Type_of_Adenocarcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	863	0	863	0	863	0	863	1
TCGA-JW-A852	CESC	42	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	New_Primary_Tumor	Complete_Remission/Response	1	252	1	252	0	252	1	153	1
TCGA-JW-AAVH	CESC	46	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	552	0	552	0	552	0	552	2
TCGA-JX-A3PZ	CESC	25	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	642	1	642	1	491	1	491	1
TCGA-JX-A3Q0	CESC	63	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_III	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	6375	0	6375	0	6375	0	6375	4
TCGA-JX-A3Q8	CESC	40	FEMALE	ASIAN	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1357	0	1357	0	1357	0	1357	1
TCGA-JX-A5QV	CESC	37	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	636	0	636	0	636	0	636	1
TCGA-LP-A4AU	CESC	35	FEMALE	ASIAN	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	NA	0	343	0	343	NA	NA	0	343	1
TCGA-LP-A4AV	CESC	63	FEMALE	ASIAN	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	NA	0	0	0	0	NA	NA	0	0	1
TCGA-LP-A4AW	CESC	52	FEMALE	ASIAN	Stage_IA	Cervical_Squamous_Cell_Carcinoma	G1	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	NA	0	27	0	27	NA	NA	0	27	1
TCGA-LP-A4AX	CESC	45	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	380	0	380	0	380	0	380	1
TCGA-LP-A5U2	CESC	30	FEMALE	ASIAN	Stage_IIIB	Endocervical_Adenocarcinoma_of_the_Usual_Type	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	9	0	9	0	9	0	9	1
TCGA-LP-A5U3	CESC	40	FEMALE	ASIAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	25	0	25	0	25	0	25	1
TCGA-LP-A7HU	CESC	53	FEMALE	ASIAN	Stage_II	Endocervical_Type_of_Adenocarcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	406	0	406	0	406	0	406	1
TCGA-MA-AA3W	CESC	54	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	685	0	685	0	685	0	685	2
TCGA-MA-AA3X	CESC	50	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	617	0	617	0	617	0	617	2
TCGA-MA-AA3Y	CESC	48	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	542	0	542	0	542	0	542	1
TCGA-MA-AA3Z	CESC	43	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	595	0	595	0	595	0	595	1
TCGA-MA-AA41	CESC	33	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	0	279	0	279	NA	NA	0	279	2
TCGA-MA-AA42	CESC	75	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	259	0	259	0	259	0	259	1
TCGA-MA-AA43	CESC	48	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	346	0	346	0	346	0	346	4
TCGA-MU-A51Y	CESC	27	FEMALE	WHITE	Stage_IIA1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	854	0	854	0	854	0	854	1
TCGA-MU-A5YI	CESC	60	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IA1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	NA	0	1053	0	1053	NA	NA	1	630	3
TCGA-MU-A8JM	CESC	46	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	607	0	607	0	607	0	607	4
TCGA-MY-A5BD	CESC	62	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Stable_Disease	0	1667	0	1667	NA	NA	0	1667	1
TCGA-MY-A5BE	CESC	42	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1066	0	1066	0	1066	0	1066	1
TCGA-MY-A5BF	CESC	68	FEMALE	WHITE	Stage_IIA2	Cervical_Squamous_Cell_Carcinoma	G1	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Stable_Disease	0	634	0	634	NA	NA	0	634	1
TCGA-MY-A913	CESC	28	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIA	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	524	0	524	0	524	0	524	5
TCGA-PN-A8MA	CESC	43	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Stable_Disease	0	90	0	90	NA	NA	0	90	NA
TCGA-Q1-A5R1	CESC	32	FEMALE	WHITE	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	474	0	474	0	474	0	474	1
TCGA-Q1-A5R2	CESC	64	FEMALE	WHITE	NA	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	NA	0	499	0	499	NA	NA	0	499	1
TCGA-Q1-A5R3	CESC	56	FEMALE	WHITE	NA	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	485	0	485	0	485	0	485	1
TCGA-Q1-A6DT	CESC	55	FEMALE	WHITE	Stage_I	Cervical_Squamous_Cell_Carcinoma	GX	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	275	1	275	NA	NA	1	275	1
TCGA-Q1-A6DV	CESC	36	FEMALE	ASIAN	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	491	0	491	0	491	0	491	1
TCGA-Q1-A6DW	CESC	44	FEMALE	WHITE	Stage_I	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	NA	NA	NA	0	534	0	534	NA	NA	0	534	4
TCGA-Q1-A73O	CESC	37	FEMALE	NA	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	428	0	428	0	428	0	428	1
TCGA-Q1-A73P	CESC	45	FEMALE	WHITE	Stage_IB1	Endocervical_Type_of_Adenocarcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	483	0	483	0	483	0	483	1
TCGA-Q1-A73Q	CESC	46	FEMALE	WHITE	Stage_I	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	NA	0	284	0	284	NA	NA	0	284	2
TCGA-Q1-A73R	CESC	45	FEMALE	WHITE	Stage_I	Endocervical_Type_of_Adenocarcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	567	0	567	0	567	0	567	1
TCGA-Q1-A73S	CESC	33	FEMALE	WHITE	Stage_IB1	Adenosquamous	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	688	0	688	0	688	0	688	4
TCGA-R2-A69V	CESC	42	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	596	0	596	0	596	0	596	1
TCGA-RA-A741	CESC	34	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	444	0	444	0	444	0	444	4
TCGA-UC-A7PD	CESC	21	FEMALE	AMERICAN_INDIAN_OR_ALASKA_NATIVE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Locoregional_Recurrence	Complete_Remission/Response	1	355	1	355	1	202	1	202	2
TCGA-UC-A7PF	CESC	44	FEMALE	NA	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	NA	NA	NA	1	2859	NA	2859	NA	NA	0	2859	2
TCGA-UC-A7PG	CESC	44	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	1	370	1	370	NA	NA	1	370	2
TCGA-UC-A7PI	CESC	44	FEMALE	WHITE	Stage_IB1	Endometrioid_Adenocarcinoma_of_Endocervix	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	Locoregional_Recurrence	Complete_Remission/Response	0	2114	0	2114	1	778	1	778	1
TCGA-VS-A8EB	CESC	41	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	1	305	1	305	NA	NA	1	305	2
TCGA-VS-A8EC	CESC	55	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	1415	0	1415	0	1415	0	1415	NA
TCGA-VS-A8EG	CESC	36	FEMALE	NA	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	GX	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	1386	0	1386	0	1386	0	1386	1
TCGA-VS-A8EH	CESC	56	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	986	0	986	0	986	0	986	2
TCGA-VS-A8EI	CESC	38	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	729	0	729	0	729	0	729	1
TCGA-VS-A8EJ	CESC	60	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Progressive_Disease	1	607	1	607	NA	NA	1	607	1
TCGA-VS-A8EL	CESC	38	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1992	0	1992	0	1992	0	1992	1
TCGA-VS-A8Q8	CESC	26	FEMALE	WHITE	Stage_IB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Locoregional_Recurrence	Progressive_Disease	1	978	1	978	NA	NA	1	488	1
TCGA-VS-A8Q9	CESC	79	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1630	0	1630	0	1630	0	1630	1
TCGA-VS-A8QA	CESC	44	FEMALE	NA	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	GX	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	1099	0	1099	0	1099	0	1099	1
TCGA-VS-A8QC	CESC	51	FEMALE	WHITE	Stage_IVA	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	350	1	350	NA	NA	1	263	2
TCGA-VS-A8QF	CESC	42	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1800	0	1800	0	1800	0	1800	4
TCGA-VS-A8QH	CESC	76	FEMALE	WHITE	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Partial_Remission/Response	1	1210	1	1210	NA	NA	1	1210	1
TCGA-VS-A8QM	CESC	47	FEMALE	NA	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	GX	NA	WITH_TUMOR	NA	Progressive_Disease	1	951	1	951	NA	NA	1	951	2
TCGA-VS-A94W	CESC	39	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1243	0	1243	0	1243	0	1243	1
TCGA-VS-A94X	CESC	40	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	WITH_TUMOR	NA	Partial_Remission/Response	1	506	1	506	NA	NA	1	506	1
TCGA-VS-A94Y	CESC	47	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	1	144	1	144	NA	NA	1	144	2
TCGA-VS-A94Z	CESC	38	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1015	0	1015	0	1015	0	1015	4
TCGA-VS-A950	CESC	42	FEMALE	NA	Stage_IIIA	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Partial_Remission/Response	0	1221	0	1221	NA	NA	0	1221	1
TCGA-VS-A952	CESC	66	FEMALE	WHITE	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1778	0	1778	0	1778	0	1778	1
TCGA-VS-A953	CESC	63	FEMALE	NA	Stage_IVA	Cervical_Squamous_Cell_Carcinoma	GX	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	Partial_Remission/Response	1	477	1	477	NA	NA	1	477	1
TCGA-VS-A954	CESC	67	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1714	0	1714	0	1714	0	1714	1
TCGA-VS-A957	CESC	64	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1688	0	1688	0	1688	0	1688	1
TCGA-VS-A958	CESC	46	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1525	0	1525	0	1525	0	1525	1
TCGA-VS-A959	CESC	76	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	1561	0	1561	0	1561	0	1561	1
TCGA-VS-A9U5	CESC	57	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	1535	0	1535	0	1535	0	1535	1
TCGA-VS-A9U6	CESC	52	FEMALE	WHITE	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Stable_Disease	0	1320	0	1320	NA	NA	1	711	1
TCGA-VS-A9U7	CESC	30	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	1472	0	1472	0	1472	0	1472	1
TCGA-VS-A9UB	CESC	54	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	911	0	911	0	911	0	911	1
TCGA-VS-A9UC	CESC	32	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	WITH_TUMOR	NA	Stable_Disease	0	825	0	825	NA	NA	0	825	1
TCGA-VS-A9UD	CESC	73	FEMALE	WHITE	Stage_IIIA	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	739	0	739	0	739	0	739	1
TCGA-VS-A9UH	CESC	53	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IVA	Cervical_Squamous_Cell_Carcinoma	GX	NA	TUMOR_FREE	NA	Complete_Remission/Response	0	1427	0	1427	NA	NA	0	1427	1
TCGA-VS-A9UI	CESC	76	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	GX	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	1	1372	0	1372	0	1372	0	1372	1
TCGA-VS-A9UJ	CESC	55	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	NA	1	52	1	52	NA	NA	1	52	1
TCGA-VS-A9UL	CESC	79	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	442	1	442	NA	NA	1	336	1
TCGA-VS-A9UM	CESC	39	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	1	829	0	829	NA	NA	0	829	1
TCGA-VS-A9UO	CESC	43	FEMALE	WHITE	Stage_IIB	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	1456	0	1456	0	1456	0	1456	1
TCGA-VS-A9UP	CESC	43	FEMALE	NA	Stage_IIA	Mucinous_Adenocarcinoma_of_Endocervical_Type	G3	Peri_(6-12_months_since_last_menstrual_period)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	1444	0	1444	1	352	1	352	2
TCGA-VS-A9UQ	CESC	32	FEMALE	NA	Stage_IB	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	Distant_Metastasis	Complete_Remission/Response	0	1263	0	1263	1	561	1	561	1
TCGA-VS-A9UR	CESC	53	FEMALE	WHITE	Stage_IIA	Mucinous_Adenocarcinoma_of_Endocervical_Type	GX	NA	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	793	0	793	1	675	1	675	1
TCGA-VS-A9UT	CESC	72	FEMALE	ASIAN	Stage_IB	Mucinous_Adenocarcinoma_of_Endocervical_Type	G3	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	TUMOR_FREE	NA	Complete_Remission/Response	0	482	0	482	0	482	0	482	1
TCGA-VS-A9UU	CESC	42	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G1	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	442	0	442	0	442	0	442	2
TCGA-VS-A9UV	CESC	74	FEMALE	NA	Stage_IVA	Cervical_Squamous_Cell_Carcinoma	GX	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	1	104	1	104	NA	NA	1	104	1
TCGA-VS-A9UY	CESC	29	FEMALE	NA	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	G2	NA	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	555	1	555	NA	NA	1	412	1
TCGA-VS-A9UZ	CESC	61	FEMALE	WHITE	Stage_IB1	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	2044	0	2044	0	2044	0	2044	1
TCGA-VS-A9V0	CESC	58	FEMALE	NA	Stage_IB	Mucinous_Adenocarcinoma_of_Endocervical_Type	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	573	0	573	1	475	1	475	4
TCGA-VS-A9V1	CESC	46	FEMALE	WHITE	Stage_IVB	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	Distant_Metastasis	Progressive_Disease	1	157	1	157	NA	NA	1	58	2
TCGA-VS-A9V2	CESC	29	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	TUMOR_FREE	NA	Complete_Remission/Response	0	555	0	555	0	555	0	555	1
TCGA-VS-A9V3	CESC	62	FEMALE	WHITE	Stage_IVB	Cervical_Squamous_Cell_Carcinoma	G3	NA	WITH_TUMOR	Distant_Metastasis	Complete_Remission/Response	0	540	0	540	NA	NA	1	456	1
TCGA-VS-A9V4	CESC	63	FEMALE	WHITE	Stage_IVA	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	New_Primary_Tumor	NA	1	132	1	132	NA	NA	1	100	4
TCGA-VS-A9V5	CESC	50	FEMALE	WHITE	Stage_IIB	Mucinous_Adenocarcinoma_of_Endocervical_Type	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	WITH_TUMOR	NA	Progressive_Disease	1	494	1	494	NA	NA	1	494	1
TCGA-VS-AA62	CESC	51	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	Peri_(6-12_months_since_last_menstrual_period)	WITH_TUMOR	NA	Progressive_Disease	1	469	1	469	NA	NA	1	469	1
TCGA-WL-A834	CESC	57	FEMALE	WHITE	NA	Cervical_Squamous_Cell_Carcinoma	G3	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Partial_Remission/Response	0	791	0	791	NA	NA	0	791	4
TCGA-XS-A8TJ	CESC	41	FEMALE	BLACK_OR_AFRICAN_AMERICAN	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	TUMOR_FREE	NA	Complete_Remission/Response	0	890	0	890	0	890	0	890	5
TCGA-ZJ-A8QO	CESC	73	FEMALE	NA	NA	Cervical_Squamous_Cell_Carcinoma	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-A8QR	CESC	38	FEMALE	NATIVE_HAWAIIAN_OR_OTHER_PACIFIC_ISLANDER	Stage_I	Cervical_Squamous_Cell_Carcinoma	GX	Pre_(<6_months_since_LMP_AND_no_prior_bilateral_ovariectomy_AND_not_on_estrogen_replacement)	NA	NA	NA	1	582	NA	582	NA	NA	0	582	2
TCGA-ZJ-AAX4	CESC	85	FEMALE	WHITE	Stage_II	Cervical_Squamous_Cell_Carcinoma	G3	NA	NA	NA	NA	0	21	0	21	NA	NA	0	21	4
TCGA-ZJ-AAX8	CESC	58	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-AAXA	CESC	64	FEMALE	WHITE	Stage_IB1	Cervical_Squamous_Cell_Carcinoma	G2	NA	NA	NA	NA	0	43	0	43	NA	NA	0	43	3
TCGA-ZJ-AAXB	CESC	42	FEMALE	WHITE	Stage_IB2	Endocervical_Adenocarcinoma_of_the_Usual_Type	G3	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	1
TCGA-ZJ-AAXD	CESC	35	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-AAXF	CESC	62	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G3	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-AAXI	CESC	67	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-AAXJ	CESC	43	FEMALE	NA	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-AAXN	CESC	34	FEMALE	WHITE	Stage_IB2	Cervical_Squamous_Cell_Carcinoma	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	2
TCGA-ZJ-AAXT	CESC	54	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	4
TCGA-ZJ-AAXU	CESC	51	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	G2	NA	NA	NA	NA	0	5	0	5	NA	NA	0	5	2
TCGA-ZJ-AB0H	CESC	48	FEMALE	NA	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	NA
TCGA-ZJ-AB0I	CESC	25	FEMALE	WHITE	Stage_IIB	Cervical_Squamous_Cell_Carcinoma	NA	NA	NA	NA	NA	0	0	0	0	NA	NA	0	0	4
TCGA-ZX-AA5X	CESC	64	FEMALE	WHITE	Stage_IIIB	Cervical_Squamous_Cell_Carcinoma	G2	Post_(prior_bilateral_ovariectomy_OR_>12_mo_since_LMP_with_no_prior_hysterectomy)	WITH_TUMOR	NA	NA	0	119	0	119	NA	NA	0	119	1
